House spending panel restores US ban on gene-edited babies

Tuesday, June 4, 2019

Science – By voice vote, the full Appropriations Committee of the House of Representatives today restored language to a 2020 spending bill that bars the Food and Drug Administration (FDA) from considering requests to approve any clinical trial “in which a human embryo is intentionally created or modified to include a heritable genetic modification.”